Skip to main content
Clinical Trials/NCT06233851
NCT06233851
Completed
N/A

Prospective Paediatric Cohort Study of Biomarkers in the Early Management of Mild Traumatic Brain Injury and Prediction of Persistent Post-concussion Symptoms

Pediatric Clinical Research Platform1 site in 1 country600 target enrollmentOctober 6, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Mild Traumatic Brain Injury
Sponsor
Pediatric Clinical Research Platform
Enrollment
600
Locations
1
Primary Endpoint
intracranial injuries on CT scan
Status
Completed
Last Updated
last year

Overview

Brief Summary

The goal of this observational study is to identify blood biomarkers that could help in the management of paediatric patients with mild TBI. The main questions it aims to answer are:

  1. How can blood biomarkers reduce unnecessary CT scan and reduce the length of stay at the emergency department?
  2. How can blood biomarker predict post-concussion symptoms?

Participants will have a blood sample taken when they are admitted at emergency department and will receive a questionnaire describing their symptoms 14 days and 3 months after their trauma.

Detailed Description

Mild Traumatic Brain Injury (mTBI) in children is a very frequent reason for presentation at the paediatric emergency department. In most cases, the trauma will not lead to intracranial lesions. The first objective for clinicians is therefore to detect all children in need of neurosurgical intervention after mTBI. Although computerized tomography (CT) is currently the modality of choice for acute intracranial haemorrhage identification, care should be taken to avoid unnecessary exposure to ionizing radiation in the developing brain. Monitoring the occurrence of bleeding usually involves an observation period which generally extends from six to twenty-four hours. This time is stressful for the child and parents as well as time and cost consuming for the hospital. In addition to the acute conditions, it has been described that post-concussion symptoms can occur in the weeks or months following the trauma, and neuropsychological follow-up of these children could help prevent or reduce the symptoms. The aim of our study is to find biomarkers that can identify children with clinically important intracranial injury and/or children that will eventually suffer from a post-concussion syndrome.

Registry
clinicaltrials.gov
Start Date
October 6, 2020
End Date
July 8, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Pediatric Clinical Research Platform
Responsible Party
Principal Investigator
Principal Investigator

Sergio MANZANO

professor

Pediatric Clinical Research Platform

Eligibility Criteria

Inclusion Criteria

  • mTBI within 24 hours

Exclusion Criteria

  • refusal of child or parents
  • evidence of intoxication with alcohol or other substances
  • history of TBI ( less than one month)
  • epilepsy, encephalitis, meningitis, melanoma

Outcomes

Primary Outcomes

intracranial injuries on CT scan

Time Frame: Admission; within 24 hours

Hemorrhage, oedema, traumatic infarction, diffuse axonal injury, pneumocephalus

Post concussion symptoms

Time Frame: 3 months

Such as persistent headache, fatigue, concentration difficulty etc. Evaluated by a neuropsychologist and results of the PCSI score (post concussion symptoms inventory)

Study Sites (1)

Loading locations...

Similar Trials